"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...

TPAG highlights on urgent, systemic reforms to protect transfusion-dependent patients: Our Bureau, Bengaluru Wednesday, January 14, 2026, 15:15 Hrs [IST] Thalassemia Patients Advo ...

New York, United States, January 7th, 2026, FinanceWireGlobal investment management leader Aurum Capital has announced the ...

Innovation is at its peak in the Zacks Medical-Drugs industry. SLNO, NKTR, RIGL, IRWD and MRKR may prove to be good additions ...

Soleno Therapeutics leads a rebound in small drug stocks as innovation, pipeline progress and M&A activity fuel optimism for ...

Round led by new investor Life Sciences at Goldman Sachs Alternatives with participation by new investor the Retinal ...

By integrating NVIDIA’s digital twins, foundation models, and perception AI, Multiply Labs is pioneering a new era of robotic ...

As AstraZeneca floods money into the U.S. market with a wide-ranging investment plan, the company has tapped an in-house ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...